Dopaminergic receptors in the human skin

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 4, 2012, Pages 789-795

  Tammaro, Antonella ^a   Cavallotti, C ^a,b   Gaspari, A A ^c   Narcisi, A ^a   Parisella, F R ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d University of Towson (Maryland)   (United States)

Author keywords

Corneal layer; Dopamine; Human plantar skin; Neurotransmitter

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENZAZEPINE DERIVATIVE; SPIPERONE;

ARTICLE; AUTOPSY; AUTORADIOGRAPHY; BODY WEIGHT; DERMIS; DISSOCIATION CONSTANT; EPIDERMIS; HISTOLOGY; HUMAN; IMAGE ANALYSIS; MICROSCOPY; NERVE FIBER; QUANTITATIVE ANALYSIS; RADIOCHEMISTRY; SKIN; SKIN BLOOD FLOW; SUBCUTANEOUS TISSUE; CHEMISTRY; LETTER; METABOLISM;

AUTORADIOGRAPHY; BENZAZEPINES; HUMANS; NERVE FIBERS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SKIN; SPIPERONE;

EID: 84876464947     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Pugliese PT. Physiology of the skin II. Allured Publishing Corporation 2001.
2. Kim BE, Leung DY. Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol Res 2012; 4(1):12-6.
3. Elias PM, Feingold KR. Coordinate regulation of epidermal differentiation and barrier homeostasis. Skin Pharmacol Appl Skin Physiol 2001; 14:28-34. (Pubitemid 34299161)
4. Shome S, Dasgupta PS, Basu S. Dopamine regulates mobilization of mesenchymal stem cells during wound angiogenesis. PLoS one 2012; 7(2):1-12.
5. Watson S, Arkinstall S. Dopamine receptors. In: Watson S, Arkinstall S (eds). The G-protein linked receptor fact book. London, UK: Academic Press 1994; 97:110
6. Caine SB, Negus SS, Mello NK, et al. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor agonists. J Neurosci 2002; 22(7):2977-88. (Pubitemid 37465846)
7. Missale C, Nash SR et al. Dopamine receptors: from structure to function. Physiol Rev 1998; 78(1):189-225. (Pubitemid 28070979)
8. Vallone D, Picetti R, Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev 2000; 24(1):125-32. (Pubitemid 30026154)
9. Cavallotti C. Dopamine receptors in rat dura mater. Pharmacological characteristics (in coll with Frati A, Cavallotti D, Tranquilli Leali FM). Clinical and Experimental Pharmacology and Phisiology 2004; 31:190-94. (Pubitemid 38338718)
10. Cavallotti C. Dopaminergic receptors in the human dura mater (in coll with Tranquilli Leali FM, Cavallotti D, Tonnarini GF). Neurochemical Research 2004; 29:1499-504. (Pubitemid 38860230)
11. Townsend FM. Manual of the histologic and special staining techniques. McGraw Hill 1960;
12. Bodian D. A new method for staining nerve fibres and nerve ending in mounted paraffin sections. Anat Rec 1936; 65:89.
13. Cheng YC, Prussoff WH. Relationship between inhibition constant (ki) and the concentration of inhibitor which causes 50 per cent of inhibition (IC-50) of an enzymatic reaction. Biochem Pharmacol 1973;22(23):3099-108.
14. Shigeyoshi F, Suzuki A, Inoue K, Denda M. Dopamine D2-like receptor agonists accelerate barrier repair and inhibit the epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 2005; 125:783-89.